COVID-19 Vaccine Update: Valley is offering walk-ins and appointments to receive a booster dose of the Pfizer vaccine to patients who meet specific criteria. Initial doses are also available. Click to learn more and to schedule an appointment.

Clinical Trials

To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.

For more information about any of our clinical trials, please email clinicaltrialsresearch@valleyhealth.com or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)

Learn more about research and clinical trials at Valley.

BAROS

Bariatric Atrial Restoration of Sinus

Principal Investigator(s):

Suneet Mittal, MD

AMAZE

LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT™ SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION

Principal Investigator(s):

Dan L. Musat, MD

ARTESiA

Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub-Clinical Atrial Fibrillation

Principal Investigator(s):

Suneet Mittal, MD

Cardiofit

Impact of a Structured Cardiac Rehabilitation Program on Cardiorespiratory Fitness in Patients with Atrial Fibrillation

Principal Investigator(s):

Suneet Mittal, MD

DRESSLER

Anti-Heart Antibodies Can Predict Early Development of Dressler/s Syndrome After Hybrid Ablation

Principal Investigator(s):

Tina C. Sichrovsky, MD

ENVELOPE

A Randomized Noninferiority Study of the TYRX-A Antibacterial Envelope Alone Versus Envelope Plus Intraoperative Antibacterial Irrigant and Postoperative Oral Antibiotics to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Patients

Principal Investigator(s):

Suneet Mittal, MD

FROzEN-AF

Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Principal Investigator(s):

Suneet Mittal, MD

MARVEN

Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy (MARVEN Study)

Principal Investigator(s):

Dan L. Musat, MD

OPTIMIZER SMART (PAS)

A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER Smart With CCM Therapy as Standard of Care

Principal Investigator(s):

Suneet Mittal, MD

OPTION

Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation (OPTION)

Principal Investigator(s):

Suneet Mittal, MD